America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A practical guide to selecting between total market and total world funds for retirement, focusing on goals, risk tolerance, and costs.
28,577 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Dubai faces a destabilizing jolt as Iran launches strikes across the Gulf, prompting market turmoil, travel disruptio...
A provocative SXSW moment spurred a wave of Gen Z investing chatter, with young traders leaning into memes, predictio...
As market volatility persists in mid-2026, five high-quality dividend stocks appear especially compelling for income ...
A high-profile critique of a blockbuster series shines a light on how media can nudge spending habits. This article b...
Investors weigh whether the next policy move could target Cuba after Venezuela and Iran, a shift that could ripple th...
As oil markets wobble, a fee-based midstream leader stands out for steady cash flow and growing backlog. Investors ar...
Divorce becomes a high-stakes financial exercise when billions are on the line. This guide breaks down practical step...
Geopolitical strains in the Gulf collide with political turbulence in Washington, delivering a fresh round of market ...
A venture-backed biotech startup unveils a plan to collect genomic data from 100 million species to fuel AI drug disc...
New data from Goldman Sachs shows AI-driven job losses remain concentrated in early-career roles, with Gen Z bearing ...
A high-profile Pentagon briefing in Brussels on a NATO trip sparks a six-month review of American forces in Europe. M...